Regenxbio Inc (NAS:RGNX)
$ 14.42 0.07 (0.49%) Market Cap: 710.27 Mil Enterprise Value: 451.43 Mil PE Ratio: 0 PB Ratio: 1.81 GF Score: 59/100

Q1 2021 Regenxbio Inc Earnings Call Transcript

May 05, 2021 / 08:30PM GMT
Release Date Price: $32.46 (-1.87%)
Operator

Good afternoon, and welcome to the REGENXBIO First Quarter 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the call over to Mr. Patrick Christmas, Chief Legal Officer of REGENXBIO. You may begin.

Patrick J. Christmas
REGENXBIO Inc. - Senior VP & Chief Legal Officer

Good afternoon, and thank you for joining us. With us today are Ken Mills, REGENXBIO's President and Chief Executive Officer; and Dr. Steve Pakola, our Chief Medical Officer.

Earlier this afternoon, REGENXBIO released financial and operating results for the first quarter ended March 31, 2021. The press release reporting our financial results is available on our website at www.regenxbio.com.

Today's conference call will include forward-looking statements regarding our financial outlook, in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot